Physician Assistant, Medical · Philadelphia, PA
NPI
1689223299
Since 2019
Specialty
Physician Assistant, Medical
Code 363AM0700X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
834 Walnut St Ste 650
Philadelphia, PA, 19107
Phone (215) 955-5161
Groups this clinician bills Medicare through
Medicare paid, 2024
$14K
224 services
Medicare patients, 2024
135
Average age 72
Drug cost, 2024
$2.0M
2,186 prescriptions
Company payments, 2025
$799
From 6 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Emily J Littman was code 99214 (office e&m - established), 173 times for 114 patients. In total Emily J Littman billed 224 services in 9 codes, and Medicare paid $14K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-10-10.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 173 | 114 | $61.10 | $11K |
| 99204 Office E&M - New | Facility | 17 | 17 | $85.80 | $1,459 |
| 99213 Office E&M - Established | Facility | 11 | 11 | $45.22 | $497 |
By year: 2022 $2,342 for 33 services; 2023 $16K for 239 services; 2024 $14K for 224 services.
Medicare prescription drug claims, 2024
In 2024, the drug Emily J Littman prescribed most often to Medicare patients was Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter), with 275 prescriptions and refills. In total Emily J Littman wrote 2,186 Medicare prescriptions that cost $2.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 275 | 335 | 68 | $210K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 209 | 244 | 72 | $7,808 |
| Fluticasone Propionate Generic | 141 | 272 | 60 | $1,867 |
| Breo Ellipta Fluticasone/Vilanterol | 135 | 169 | 35 | $66K |
| Montelukast Sodium Generic | 126 | 268 | 41 | $1,455 |
| Dupixent Pen Dupilumab | 107 | 111 | 17 | $397K |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 103 | 127 | 23 | $79K |
| Spiriva Respimat Tiotropium Bromide | 102 | 126 | 25 | $64K |
| Prednisone Generic | 76 | 85 | 34 | $266 |
| Tezspire Tezepelumab-Ekko | 70 | 70 | Under 11 | $298K |
| Azelastine Hcl Generic | 67 | 123 | 25 | $1,358 |
| Fasenra Pen Benralizumab | 58 | 102 | 17 | $320K |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 54 | 69 | 11 | $31K |
| Budesonide-Formoterol Fumarate Budesonide/Formoterol Fumarate | 48 | 62 | 16 | $10K |
| Ipratropium Bromide Generic | 46 | 74 | 21 | $1,603 |
Brand drugs: 1,434 claims; generic drugs: - claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Emily J Littman $799 ($799 in general payments such as food, travel and fees) from 6 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $265.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.